|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.160 CNY | +1.56% |
|
-0.69% | -17.13% |
| Market Cap | 3.66B 538M 470M 432M 403M 764M 51.24B 776M 5.2B 2.02B 25.13B 2.02B 1.98B 86.61B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.18B 468M 409M 375M 350M 664M 44.53B 675M 4.52B 1.75B 21.84B 1.76B 1.72B 75.26B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.21% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | +1.56% | ||
| 1 week | -0.69% | ||
| Current month | +5.14% | ||
| 1 month | -7.61% | ||
| 3 months | -19.73% | ||
| 6 months | -17.13% | ||
| Current year | -17.13% |
| 1 week | 6.63 | 7.25 | |
| 1 month | 6.63 | 7.73 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.85 | |
| 3 years | 5.84 | 12.19 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 2022-04-05 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 2022-12-01 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 71 | 2022-05-11 |
Xin Min Zhao
BRD | Director/Board Member | 56 | 2020-01-01 |
Wen Bo Su
CHM | Chairman | 60 | 2014-05-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.56% | -0.69% | -13.84% | -41.31% | 538M | ||
| +1.65% | +3.41% | -12.27% | -7.09% | 12.81B | ||
| +0.13% | +1.75% | -35.08% | -59.56% | 4.7B | ||
| +2.30% | +7.71% | -7.97% | -11.88% | 4.45B | ||
| +0.65% | +1.44% | +8.96% | -39.86% | 3.8B | ||
| +2.01% | +5.82% | +16.27% | -12.90% | 3.84B | ||
| -0.09% | -12.55% | -13.92% | -22.73% | 3.04B | ||
| +1.18% | +1.33% | -12.08% | -5.17% | 3.03B | ||
| +0.80% | +1.27% | -7.04% | -26.27% | 2.36B | ||
| +3.25% | +6.45% | -10.89% | +28.39% | 1.71B | ||
| Average | +1.34% | +3.78% | -8.79% | -19.84% | 4.03B | |
| Weighted average by Cap. | +1.33% | +4.09% | -9.50% | -18.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 144M 126M 116M 108M 205M 13.74B 208M 1.39B 540M 6.74B 542M 530M 23.22B | 916M 135M 118M 108M 101M 191M 12.83B 194M 1.3B 505M 6.29B 506M 495M 21.69B |
| Net income | 60.07M 8.84M 7.73M 7.1M 6.62M 12.54M 842M 12.76M 85.44M 33.11M 413M 33.21M 32.48M 1.42B | 49.21M 7.24M 6.33M 5.81M 5.42M 10.28M 690M 10.45M 69.99M 27.12M 338M 27.2M 26.61M 1.17B |
| Net Debt | -357M -52.57M -45.94M -42.18M -39.34M -74.58M -5B -75.84M -508M -197M -2.45B -197M -193M -8.46B | -479M -70.52M -61.62M -56.58M -52.77M -100M -6.71B -102M -681M -264M -3.29B -265M -259M -11.35B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | CN¥7.160 | +1.56% | 4,391,350 |
| 26-07-01 | CN¥7.050 | +3.52% | 6,086,950 |
| 26-06-30 | CN¥6.810 | -5.15% | 9,294,400 |
| 26-06-29 | CN¥7.180 | +2.13% | 4,312,800 |
| 26-06-26 | CN¥7.030 | -2.50% | 3,517,400 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















